Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUpgrade notice added with operating status guidance and new version v3.2.0; previous version v3.1.0 removed.SummaryDifference4%
- Check18 days agoChange DetectedUpdates include new contact details and a new version release (v3.1.0); a specific resource reference (Ovarian cancer) and the older version (v3.0.2) were removed.SummaryDifference0.6%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. Back to Top removed; no other substantive changes detected.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated to include information on ovarian cancer under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.6%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of new resources related to ovarian cancer and the introduction of a new facility name and location, while removing several previous references to ovarian cancer and related topics.SummaryDifference5%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.